Netherlands· NL-133a15690507
Namuscla 167 mg harde capsules
A other drugs for disorders of the musculo-skeletal system product containing mexiletinehydrochloride, registered in Netherlands by Lupin (Europe) Limited. The same ATC class is registered in 2 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Mexiletinehydrochloride is registered in 2 of 19 countries.
Countries holding a registration under ATC M09AX (other drugs for disorders of the musculo-skeletal system), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 1 of them publish a price we can compare per daily dose
Mexiletinehydrochloride · ATC M09AX
2 / 19 countries
- Netherlands
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- MEXILETINEHYDROCHLORIDE
- Manufacturer
- Lupin (Europe) Limited
- Country
- Netherlands (NL)
- ATC code
- M09AX
- ATC class
- Other drugs for disorders of the musculo-skeletal system
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/18/1325
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mexiletinehydrochloride in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMexiletine hydrochloride 200mg (Mexiletine 167mg) capsulesColonis Pharma Ltd
- CzechiaNAMUSCLALupin Europe GmbH, Frankfurt am Main
- FinlandNamusclaLupin Europe GmbH
- FranceNAMUSCLA 167 mg, gélulesLUPIN EUROPE (ALLEMAGNE)
- IrelandNamuscla 167 mg hard capsulesLupin Europe GmbH
- IcelandNamusclaLupin Europe GmbH
- NorwayNamusclaLupin (Europe) Limited
- PolandNamusclaLupin Europe GmbH
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Germany · Zunmyro, Zunmyro 200 Mg Hartkapseln
- Denmark · Dopital
- Finland · Dopital
- France · Makmorsa
- United Kingdom (Northern Ireland) · Mexiletine Hydrochloride Clinigen Healthcare, Mexiletine Hydrochloride Waymade
- Hungary · Ritalmex
- Norway · Dopital
- Sweden · Dopital
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/64a71852-a808-4912-b85d-e232026de365 GET /v1/drugs/64a71852-a808-4912-b85d-e232026de365?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/namuscla-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Other Drugs For Disorders Of The Musculo-Skel Syst",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp121562",
"excipients": [
"GELATINE (E 441)",
"IJZEROXIDE ROOD (E 172)",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"MEXILETINEHYDROCHLORIDE"
],
"leaflet_url": null,
"authorised_at": "2018/12/18",
"procedure_number": "EMEA/H/C/004584",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/18/1325",
"additional_monitoring": "N"
}See everything about mexiletinehydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.